Feasibility of dose-dense epirubicin and cyclophosphamide with subcutaneous pegfilgrastim 3.6 mg support: a single-center prospective study in Japan

Comparable efficacy and safety profiles of once-per-cycle pegfilgrastim and daily injection filgrastim inchemotherapy-induced neutropenia: a multicenterdose-finding study in women with breast cancer

Frankie A. Holmes, Stephen E. Jones, Joyce O’Shaughnessy et al. · Annals of Oncology · 2002 · 292 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +11

Fluorouracil and dose-dense chemotherapy in adjuvant treatment of patients with early-stage breast cancer: an open-label, 2 × 2 factorial, randomised phase 3 trial

Lucia Del Mastro, Sabino De Placido, Paolo Bruzzi et al. · The Lancet · 2015 · 201 citations

Medicine, Oncology, Pharmacology +15

An analysis of the utilisation of chemoprophylaxis against Pneumocystis jirovecii pneumonia in patients with malignancy receiving corticosteroid therapy at a cancer hospital

Leon J. Worth, Michael Dooley, J.F. Seymour et al. · British Journal of Cancer · 2005 · 74 citations · Full text

Pharmacy, Infectious Diseases, Oncology +13

Characterization of Endogenous G-CSF and the Inverse Correlation to Chemotherapy-Induced Neutropenia in Patients with Breast Cancer Using Population Modeling

Angelica Quartino, Mats O. Karlsson, Henrik Lindman et al. · Pharmaceutical Research · 2014 · 55 citations

Medicine, Cancer Biology, Oncology +9

Consensus recommendations for the prevention of vomiting and nausea following high-emetic-risk chemotherapy

Mark G. Kris, Maurizio Tonato, Emilio Bria et al. · Supportive Care in Cancer · 2010 · 48 citations · Full text

Medicine, Oncology, Pharmacotherapy +14